United States · Series A startup
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Funding summaryUpdated 26 Oct 2026
$35Mraised across 2 rounds since 2022, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Fast Track Initiative and 1 otherSEC filing: $13M sold
Mitsubishi UFJ Capital
SBI Investment
Daiwa Corporate InvestmentSource recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
This firm lists Sonire Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Sonire Therapeutics's investors include Mitsubishi UFJ Capital, SBI Investment, FTI, Nissay Capital and Daiwa Corporate Investment, and 1 more on record. FTI led its latest round.
Sonire Therapeutics has raised $35M across 2 rounds since 2022.
Sonire Therapeutics's most recent round was a Series A of $18M in Apr 2026, led by FTI.
Its most recent round, $18M in Apr 2026, is also its largest on record.
Sonire Therapeutics's first round on record, in Nov 2022, was backed by Mitsubishi UFJ Capital, SBI Investment and Nissay Capital and 2 others.
Sonire Therapeutics's latest named round is a Series A, in Apr 2026.
Sonire Therapeutics is based in the United States.
FTI led the Series A in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
